Anthropic, OpenAI proposed new 'neutral' AI watchdogs. Why you should worry about the idea
Anthropic and OpenAI are proposing embedded AI evaluators to help manage risk of models causing catastrophic harm to society, but the idea has some issues.
Anthropic, OpenAI proposed new 'neutral' AI watchdogs. Why you should worry about the idea
Anthropic and OpenAI are proposing embedded AI evaluators to help manage risk of models causing catastrophic harm to society, but the idea has some issues.
FilterCNBC
Clustered coverageCNBC
Coverage timeline1
Coverage timeline
Coverage timeline
Ranked reports inside the event cluster. Open any publisher link to read the original coverage.
Related events
Related events
Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.
6 reports3 sourcesSimilarity 0.51
AI bosses’ safety push sparks rift inside OpenAI and Anthropic
Staff at the Silicon Valley companies are grappling with how to turn AI slowdown rhetoric into reality Grouped from 6 articles across 3 sources.
CNBC, Financial Times, The Straits Times
1 report1 sourceSimilarity 0.43
What are the top threats posed by AI and should you be worried? Experts explain
The most powerful figures in the AI industry issued grave warnings in recent days.
ABC News
1 report1 sourceSimilarity 0.39
OpenAI CFO Sarah Friar tells CNBC she isn't worried about slowing AI development
Friar joined CNBC's Jim Cramer on "Mad Money" as the debate over technology's safety risks rages on.
CNBC
1 report1 sourceSimilarity 0.38
Anthropic CEO didn’t foresee the speed of global AI growth
Anthropic’s CEO says he ‘didn’t appreciate’ the speed with which AI’s growth would underpin the global economy.
Al Jazeera
1 report1 sourceSimilarity 0.35
OpenAI backs Bills in US Congress on AI and biological weapon threats
Heads of top US AI labs including OpenAI have called for a slowdown in the pace of advanced AI development.
The Straits Times
1 report1 sourceSimilarity 0.34
Danish pharma giant Novo to use Anthropic’s Claude to advance AI drug discovery
The deal underscores a broader push by drugmakers to integrate AI across research and development to boost new drug discovery.
Euronews